Deep Intelligent Pharma Secures $40 Million in New Funding Round Led by Existing Investors

Recently, DIP, a globally leading AI unicorn, announced the completion of a new $40 million funding round. This round was led by existing shareholdersCDH Baifu, New Ding Capital, Jinyi Capital, Kaitai CapitalCollective bet,Index CapitalContinue to serve as the exclusive financial advisor.

Previously, DeepGlow had completed in December 202550 millionUSD-denominated Series D financing, completed again in February 202660 millionUSD Financing. Just one month after the previous round, the company secured additional investment from institutional investors.40 millionNew Round of USD Financing.Secured $150 million in cumulative financing within three months, the introduction of numerous top-tier shareholder institutions fully demonstrates the capital market’s high recognition and long-term confidence in Deepwise’s “AI-driven dual-wheel strategy of ‘Life Sciences + Physical Sciences’.”

Since its founding in 2017, Deep Intelligence has always stood at the forefront of the intersection between AI and science. In the field of life sciences, the company has pioneered“AI Bionic Brain + Experts” Native Organizational Model,replacing labor-intensive processes with computational power, and leveraging fundamental scientific mechanisms to drastically compress the timelines for clinical protocol design, biostatistics, and other stages of the clinical trial workflow, thereby achieving a dual leap in efficiency and precision, and redefining AI CRO.

InPhysical SciencesIn this field, the company has pioneered the application of micro-scale computational complexity in life sciences."Paradigm Shift"To materials science, constructed based on bionicsMateriaOS Engine, constructing a “digital wormhole” that bridges the microscopic quantum world and macroscopic industrial applications, with multi-scale modeling, molecular dynamics simulations, and generative AI—honed in the field of life sciences—as its core genetic foundation,Establish a unified computational framework spanning the entire chain from “atoms–molecules–materials–devices.”Breaking through the efficiency ceiling of the traditional “trial-and-error” approach in materials R&D, and translating the microscopic complexity of biological computation into predictive accuracy for materials design,Achieving a Paradigm Shift from “Discovering Materials” to “Creating Materials.”

Its modular architecture supports cross-domain knowledge transfer,Provide a general intelligence foundation for upper-layer vertical industry engines, with downstream coverageNew energy batteries, semiconductor materials, pesticide molecules, high-temperature-resistant alloysand other strategic tracks.

Image provided by the company

In this funding round, existing shareholders including CDH Baifu, Xinding Capital, Jinyi Capital, and Kaitai Capital continued to increase their investments. This not only affirms DeepGlow’s past achievements but also represents a firm bet on its future vision, fully demonstrating the capital market’s confidence in the company’s technological barriers, commercialization capabilities, and long-term growth potential.

This round of financing will be primarily allocated to three key areas: first, advancing the research and development of multi-matrix AGI brain-inspired models to build a multi-matrix agent system grounded in life sciences and physical sciences; second, deepening global expansion by strengthening technical delivery and business development in core markets such as China, Japan, and the United States; and third, expanding the top-tier talent pipeline by attracting leading experts from around the world at the intersection of AI and science.

The company simultaneously announced the adoption of a new slogan:
"Life Possesses Wisdom, Matter Holds Spirit"
Intelligence for Life, Materials for Future
——DeepWisdom, Joining Hands with You to Transform the Industry Landscape